


































Pharmacy Meeting Notices | Florida Agency for Health Care Administration











The state of Florida neither endorses links nor approves of links to external sources. External links are made available for the convenience of the internet user. The state of Florida takes no responsibility for a link's operation or content. The links that are shown are not an exclusive listing of organizations available within the state.
Warning: You are leaving the AHCA website





                No, Stay Here
                



                    Ok, I understand
                


















            An official website of the Florida State government.
          















                            Florida Agency for Health Care Administration
                        







About the Agency for Health Care Administration| 

Contact AHCA| 

Public Records| 

Public Meetings 






                                    Search
                                






















Medicaid




Go to Medicaid




Medicaid Policy, Quality and Operations




Medicaid Finance and Analytics




Florida Health Care Connections (FX)






Health Care Policy and Oversight




Go to Health Care Policy and Oversight




Bureau of Central Services




Bureau of Field Operations




Bureau of Health Facility Regulation




Office of Medicaid Program Integrity




Florida Center for Health Information and Transparency




Office of Plans and Construction






Agency Administration




Go to Agency Administration




About the Secretary




Chief of Staff Office




Information Technology Office




Office of Inspector General




Office of the General Counsel






Find a Facility




Careers










Pharmacy Meeting Notices












Home




Medicaid




Prescribed Drugs



Pharmacy Meeting Notices











Pharmacy Meeting NoticesThis page contains the meeting notices for the Pharmaceutical and Therapeutics Committee, and the Drug Utilization Review Board. Please check here periodically for the latest meeting dates, times, and locations.Drug Utilization Review (DUR) Board and Pharmaceutical and Therapeutics (P&T) Committee MeetingsDrug Utilization Review Board The next meeting of the DUR Board is scheduled for:Date:        Thursday, June 13, 2024Time:        1:30 – 4:30 p.m. Eastern TimeLocation:   Virtual https://primetherapeutics.zoom.us/j/82662203759Or One tap mobile:+13052241968,82662203759# US+13092053325,82662203759# USOr Telephone: Dial(for higher quality, dial a number based on your current location):           +1 305 224 1968 US      +1 309 205 3325 US      +1 312 626 6799 US (Chicago)      +1 646 558 8656 US (New York)      +1 646 931 3860 US      +1 301 715 8592 US (Washington DC)      +1 669 900 9128 US (San Jose)      +1 689 278 1000 US      +1 719 359 4580 US      +1 253 205 0468 US      +1 253 215 8782 US (Tacoma)      +1 346 248 7799 US (Houston)      +1 360 209 5623 US      +1 386 347 5053 US      +1 507 473 4847 US      +1 564 217 2000 US      +1 669 444 9171 USWebinar ID: 826 6220 3759International numbers available: https://primetherapeutics.zoom.us/u/kbvj5iPr9

    June 2024 DUR Agenda


    [
                    
                213.6 kB
    ]

NOTE:Public testimony requests for the June 13,2024 DUR Board meeting will be OPEN from 9:00AM ET on May 10, 2024 through Friday, June 7, 2024 at 9:00 AM. Those selected for public testimony must be present during the Webinar to speak. You will be notified of your selection status by 5:00PM ET on Friday, June 7, 2024. All interested parties can request a 2-minute speaker slot by completing the online form at: https://forms.office.com/g/REYd5g1HDCPharmaceutical and Therapeutics Committee The next meeting of the P&T Committee is scheduled for:Date:        Friday, June 14,  2024Time:        8:30 a.m. - 12:30 a.m. Eastern TimeLocation:  Virtual https://primetherapeutics.zoom.us/j/82962093812Or One tap mobile :+16465588656,,82962093812# US (New York)+16469313860,,82962093812# USOr Telephone:Dial(for higher quality, dial a number based on your current location):     +1 646 558 8656 US (New York)     +1 646 931 3860 US     +1 301 715 8592 US (Washington DC)     +1 305 224 1968 US     +1 309 205 3325 US     +1 312 626 6799 US (Chicago)     +1 669 444 9171 US     +1 669 900 9128 US (San Jose)     +1 689 278 1000 US     +1 719 359 4580 US     +1 253 205 0468 US     +1 253 215 8782 US (Tacoma)     +1 346 248 7799 US (Houston)     +1 360 209 5623 US     +1 386 347 5053 US     +1 507 473 4847 US     +1 564 217 2000 USWebinar ID: 829 6209 3812International numbers available: https://primetherapeutics.zoom.us/u/keAkCXXzig

    June 2024 P&T Agenda


    [
                    
                312.1 kB
    ]

NOTE:Public testimony requests for the June 14, 2024 Pharmaceutical and Therapeutics committee meeting will be OPEN from 9:00 AM ET on May 10, 2024 through Friday, June 7, 2024 at 9:00am ET.  Those selected for public testimony must be present during the Webinar to speak. You will be notified of your selection status by 5:00PM ET Friday, June 7, 2024.All interested parties can request a 2-minute speaker slot by completing the online form at: https://forms.office.com/g/TEvfD49YWn









                        Prescribed Drugs
                    





                                Additional Information
                            



                                Behavioral Health Medication Management Resources
                            



                                Counterfeit-proof Prescription Blank Program
                            



                                Drug Criteria
                            



                                Drug Utilization Review Board
                            



                                Early and Periodic Screening, Diagnostic and Treatment (EPSDT) Benefit
                            



                                Florida Medicaid Preferred Drug Program
                            



                                Medicaid Pharmaceutical & Therapeutics Committee
                            



                                Ombudsman Program
                            



                                Pharmacy Meeting Notices
                            



                                Pharmacy Reports and Presentations
                            



                                Remittance Advice Provider Alerts
                            



                                State Maximum Allowed Cost (SMAC)
                            




















Document reader download links:


 MS Word Viewer


 MS PowerPoint Viewer


 Windows Media Player


 Quicktime Media Player


 Windows Media Player


 WinRar


 Adobe PDF Reader













Return to top












ahca.myflorida.com

                                      Official website of the State of Florida
                                    










                        © 2024 Florida Agency for Health Care Administration
                    












